Kelly McQuarrie

1.1k total citations
33 papers, 634 citations indexed

About

Kelly McQuarrie is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Kelly McQuarrie has authored 33 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 7 papers in Surgery and 7 papers in Oncology. Recurrent topics in Kelly McQuarrie's work include Prostate Cancer Treatment and Research (12 papers), Management of metastatic bone disease (6 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Kelly McQuarrie is often cited by papers focused on Prostate Cancer Treatment and Research (12 papers), Management of metastatic bone disease (6 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Kelly McQuarrie collaborates with scholars based in United States, United Kingdom and Japan. Kelly McQuarrie's co-authors include Angela Lopez‐Gitlitz, Steven R. Feldman, David Cella, Chenglong Han, Kim N., Hilary H. Colwell, Susan D. Mathias, Ethan Basch, Josephine M. Norquist and Karim Fizazi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Lancet Oncology.

In The Last Decade

Kelly McQuarrie

31 papers receiving 633 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kelly McQuarrie United States	13	319	113	112	97	80	33	634
Giuseppe Fallara Italy	18	472 1.5×	75 0.7×	101 0.9×	148 1.5×	82 1.0×	120	1.0k
Wim van Dijck United States	7	117 0.4×	257 2.3×	29 0.3×	183 1.9×	25 0.3×	8	734
Ravi Potluri United States	13	77 0.2×	61 0.5×	25 0.2×	300 3.1×	21 0.3×	77	774
Stephanie L. Hines United States	15	69 0.2×	102 0.9×	17 0.2×	313 3.2×	106 1.3×	52	771
Zhangyan Lyu China	14	217 0.7×	48 0.4×	48 0.4×	334 3.4×	135 1.7×	55	828
Eleni Frangou United Kingdom	13	208 0.7×	89 0.8×	10 0.1×	53 0.5×	29 0.4×	22	794
Nathalie C. Støer Norway	14	81 0.3×	9 0.1×	41 0.4×	152 1.6×	44 0.6×	48	597
Richard Casey Canada	15	198 0.6×	17 0.2×	234 2.1×	37 0.4×	15 0.2×	41	721
Dionisios Mitropoulos Greece	16	228 0.7×	17 0.2×	100 0.9×	70 0.7×	75 0.9×	44	744
D. Thakker India	8	64 0.2×	32 0.3×	74 0.7×	46 0.5×	93 1.2×	14	486

Countries citing papers authored by Kelly McQuarrie

Since Specialization

Citations

This map shows the geographic impact of Kelly McQuarrie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly McQuarrie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly McQuarrie more than expected).

Fields of papers citing papers by Kelly McQuarrie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly McQuarrie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly McQuarrie. The network helps show where Kelly McQuarrie may publish in the future.

Co-authorship network of co-authors of Kelly McQuarrie

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly McQuarrie. A scholar is included among the top collaborators of Kelly McQuarrie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly McQuarrie. Kelly McQuarrie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Roberts, Alison, Raquel Aguiar‐Ibáñez, Harsh Shah, et al.. (2024). PCR262 Understanding the Experience of Patients With Early-Stage Cancers: A Targeted Qualitative Literature Review. Value in Health. 27(12). S558–S558. 1 indexed citations

Aguiar‐Ibáñez, Raquel, et al.. (2024). Impact of recurrence on employment, finances, and productivity for early-stage cancer patients and caregivers: US survey. Future Oncology. 21(3). 349–365. 4 indexed citations

Colosia, Ann, et al.. (2023). Systematic literature review of the signs and symptoms of respiratory syncytial virus. Influenza and Other Respiratory Viruses. 17(2). e13100–e13100. 28 indexed citations

Chan, Eric K. H., Valerie Williams, Carla DeMuro, et al.. (2023). Psychometric evaluation of the Symptoms of Infection with Coronavirus-19 (SIC): results from a cross-sectional study and a phase 3 clinical trial. Journal of Patient-Reported Outcomes. 7(1). 45–45. 2 indexed citations

DeMuro, Carla, Sheri Fehnel, Jeffrey J. Stoddard, et al.. (2022). Development of a novel patient-reported outcome measure to assess signs and symptoms of COVID-19. Journal of Patient-Reported Outcomes. 6(1). 85–85. 4 indexed citations

Agarwal, Neeraj, Kelly McQuarrie, Anders Bjartell, et al.. (2019). Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 study. The Lancet Oncology. 20(11). 1518–1530. 69 indexed citations

Condon, David, Robert S. Chapman, Sara Shaunfield, et al.. (2019). Does recall period matter? Comparing PROMIS® physical function with no recall, 24-hr recall, and 7-day recall. Quality of Life Research. 29(3). 745–753. 23 indexed citations

Chowdhury, Simon, Stéphane Oudard, Hiroji Uemura, et al.. (2019). Matching-Adjusted Indirect Comparison of Health-Related Quality of Life and Adverse Events of Apalutamide Versus Enzalutamide in Non-Metastatic Castration-Resistant Prostate Cancer. Advances in Therapy. 37(1). 512–526. 18 indexed citations

Randall, Jason A., et al.. (2019). Understanding symptomatic experience, impact, and emotional response in recently diagnosed metastatic castration-resistant prostate cancer: a qualitative study. Supportive Care in Cancer. 28(7). 3093–3101. 13 indexed citations

10.

McQuarrie, Kelly, et al.. (2018). Benefit Of Abiraterone Acetate Plus Prednisone (AA+P) Added To Androgen Deprivation Therapy (ADT) In Patients With High-Risk, Newly Diagnosed Metastatic Hormone-Sensitive Prostate Cancer (MHSPC): Post Hoc Analysis Of EQ-5D-5L From The Latitude Study. Value in Health. 21. S38–S38. 3 indexed citations

11.

Randall, Jason A., et al.. (2018). Qualitative study to understand the emotional response to a metastatic diagnosis in castration-resistant prostate cancer.. Journal of Clinical Oncology. 36(30_suppl). 201–201. 1 indexed citations

12.

Small, Eric J., David Cella, Kelly McQuarrie, et al.. (2018). Health-related quality of life (HRQoL) after progressive disease (PD) in SPARTAN: A phase III trial of apalutamide (APA) versus placebo (PBO) in men with nonmetastatic castration-resistant prostate cancer (nmCRPC). Annals of Oncology. 29. viii276–viii277. 2 indexed citations

13.

N., Kim, Andrew Protheroe, A. Rodrı́guez-Antolı́n, et al.. (2018). Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (LATITUDE): an international, randomised phase 3 trial. The Lancet Oncology. 19(2). 194–206. 113 indexed citations

14.

Karpouzas, George, Carter Thorne, Tsutomu Takeuchi, et al.. (2016). SAT0167 Health-Related Physical and Emotional Well-Being and Fatigue Improve Significantly with Sirukumab Treatment: Results of A Phase 3 Study in Patients with Active Rheumatoid Arthritis Refractory To Conventional Disease-Modifying Anti-Rheumatic Drugs. Annals of the Rheumatic Diseases. 75. 727–727.

15.

Rüdell, K., et al.. (2015). What type of response scale is the most responsive? A comprehensive review of response scale options for patient-reported outcome measures. Value in Health. 18(3). A26–A26. 1 indexed citations

16.

McQuarrie, Kelly, et al.. (2015). Content Validity of the Current Health Satisfaction Questionnaire (Ches-Q) Among People Living with Type 2 Diabetes Mellitus (T2dm) and Comorbid Chronic Kidney Disease (Ckd). Value in Health. 18(7). A710–A711. 2 indexed citations

17.

Kleinman, Leah, Sally Mannix, Lesley M. Arnold, et al.. (2014). Assessment of sleep in patients with fibromyalgia: qualitative development of the fibromyalgia sleep diary. Health and Quality of Life Outcomes. 12(1). 111–111. 25 indexed citations

18.

Norquist, Josephine M., Christine McCrary Sisk, Kelly McQuarrie, et al.. (2013). The association of flushing bother, impact, treatment satisfaction and discontinuation of niacin therapy. International Journal of Clinical Practice. 67(12). 1238–1246. 8 indexed citations

19.

Rijkelijkhuizen, J.M., Kelly McQuarrie, Cynthia J. Girman, et al.. (2009). Effects of meal size and composition on incretin, α-cell, and β-cell responses. Metabolism. 59(4). 502–511. 57 indexed citations

20.

Norquist, Josephine M., Douglas J. Watson, Qinfen Yu, et al.. (2007). Validation of a questionnaire to assess niacin-induced cutaneous flushing. Current Medical Research and Opinion. 23(7). 1549–1560. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact